CodaVax-RSV

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameCodaVax-RSV
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCD8-positive T-Lymphocytes stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth AfricaAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCodagenix Inc
China Registration ClassN/A

Develop Information

Active CompaniesCodagenix Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A